Disclaimer: This site aggregates publicly available data from official government sources (FDA, ClinicalTrials.gov, PubMed, SEC EDGAR) for general reference only. It does NOT constitute medical advice, diagnosis, treatment recommendations, or investment advice.

FDA 510(k)

AI-CVD

K-Number: K252029 · 2025-12-19

Decision Date2025-12-19
Product CodeQIH
Advisory CommitteeRA
DecisionSubstantially Equivalent

Device Summary

AI-CVD is the device name listed in this FDA 510(k) record. The listed applicant is HeartLung Corporation. It received FDA 510(k) clearance on 2025-12-19 under 510(k) number K252029. The device is classified under product code QIH. It was reviewed by the RA advisory panel. FDA Decision: Substantially Equivalent.

Frequently Asked Questions

What is the AI-CVD?

AI-CVD is a medical device that received FDA 510(k) clearance on 2025-12-19. The listed applicant is HeartLung Corporation. The 510(k) number is K252029.

When did AI-CVD receive FDA 510(k) clearance?

AI-CVD received FDA 510(k) clearance on 2025-12-19, under 510(k) number K252029.

Who is the listed applicant for AI-CVD?

The FDA 510(k) record lists HeartLung Corporation as the applicant. This does not by itself establish the device manufacturer.

What is the FDA product code for AI-CVD?

The FDA product code for AI-CVD is QIH.

Other records listing HeartLung Corporation as applicant

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Related Devices (Code: QIH)

Related records are matched automatically using names, product codes, or other metadata. A match does not establish a verified clinical, scientific, corporate, or regulatory relationship; review the linked official sources.

Official Source

View on FDA Database →

Data sourced from FDA Open API. For the most current and authoritative information, always refer to the official record.